Core Viewpoint - Shenzhen Yuntian Lifei Technology Co., Ltd. (Yuntian Lifei) is a leading AI company in China, focusing on the research, design, and commercialization of AI inference chips, and is preparing for an IPO with joint sponsors including Huatai International, CITIC Securities, and CMB International [1][5]. Company Overview - Yuntian Lifei specializes in AI inference chips, integrating deep understanding of AI algorithms and practical applications to create high-performance, cost-effective products for enterprise, consumer, and industry-level applications [5]. - The company is ranked among the top three providers of AI inference chip-related products and services in China, based on projected revenue for 2024 [5]. Product and Technology - The company's IFIC foundation enables algorithm chip integration, allowing for optimized chip designs that efficiently support multiple application scenarios [6]. - Key products include the NPU product Nova, AI inference chips (DeepEye, DeepEdge, and in-development products DeepVerse and DeepXBot), and supporting tools like Hy3CAN and IFIE software platform [6]. Market Growth - The AI inference chip market in China is experiencing rapid growth, with market size projected to increase from RMB 11.3 billion in 2020 to RMB 162.6 billion by 2024, representing a compound annual growth rate (CAGR) of 94.9% [7]. - The market is expected to continue growing at a CAGR of 53.4% from 2024 to 2029, reaching RMB 1,383 billion by 2029 [7]. Financial Performance - In the fiscal years 2022, 2023, and projected for 2024, Yuntian Lifei reported revenues of approximately RMB 546 million, RMB 506 million, and RMB 917 million, respectively [8]. - The company incurred losses of approximately RMB 448 million, RMB 384 million, and RMB 572 million for the same periods [8].